Alok Sonig, Dr. Reddy’s chief executive officer of developed markets, knows the generics business does not need a cheerleader. It’s one of the rare industry segments that prompts declarations of ...

Alok Sonig has an estimated net worth of $1.32 Million. This is based on reported shares in BAXTER INTERNATIONAL INC. Attention insiders: Dive deeper into market movements and stay ahead of the curve ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd (BSE: 500124)(NSE: DRREDDY)(NYSE: RDY) announced that the Company will be presenting at the 36th Annual J.P. Morgan ...

In a top level reshuffle, drug major Dr Reddy's Laboratories appointed Alok Sonig as Executive Vice President & Head for its generics business in North America. Sonig replaces Umang Vohra, who is ...

Baxter International Inc. (NYSE:BAX) announced that Alok Sonig, Executive Vice President and Group President, Pharmaceuticals, notified the company on November 5 of his decision to resign. According ...

The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from ...

Sonig played significant role in expanding the domestic business of Dr. Reddy's. Photo: Bharat Sai Hyderabad: Drug maker Dr. Reddy’s Laboratories Ltd on Thursday promoted Alok Sonig as executive ...

New Delhi, Sep 18 (PTI) Drug maker Lupin Tuesday said it has appointed Alok Sonig as CEO US Generics and Global Head Generics R&D & Biosimilars. Sonig will lead and have overall responsibility for the ...

India's third largest drugmaker by sales Lupin on September 18 named Alok Sonig as CEO of the crucial US generics business that contributes about 38 percent of company's revenues. Lupin had revenues ...

MUMBAI: Dr Reddy's Laboratories' North America head, Umang Vora, has quit the Hyderabad-based drugmaker, leading the company to shuffle its top management. Vora was previously the company's CFO in ...

Lupin has named Alok Sonig its new CEO of U.S. generics and global head, generics R&D and biosimilars. He will lead and have overall responsibility for Lupin's U.S. generics business, including ...